With stage III NSCLC and COPD, I chose Oasis’s integrative plan—immunotherapy, high-dose vitamin C, and respiratory support. My tumors stabilized and my breathing improved. Two years later, I’m still stable and active.
—
Robert M.
,Lung Cancer
Lung Cancer Treatment
Integrative Lung Cancer Treatment: A Comprehensive Approach to Healing
Integrative Lung Cancer Treatment: A Comprehensive Approach to Healing
Introduction
A New Perspective on Lung Cancer Treatment
Lung cancer remains one of the most challenging cancers to treat using conventional approaches alone. Even with advances in surgery, radiation, chemotherapy, targeted agents, and checkpoint inhibitors, many patients face difficult prognoses and significant side effects that can impact breathing, energy, and quality of life.
At Oasis of Hope, we believe effective care must address more than the tumor. Our integrative protocols combine evidence-based alternative therapies with conventional options when appropriate—creating personalized plans that target cancer through multiple mechanisms while supporting immune strength, metabolic health, and respiratory function.
Whether you’re newly diagnosed, seeking alternatives, or exploring options after standard treatments, our team offers advanced, whole-person care designed to restore health and offer realistic hope grounded in decades of experience with lung cancer patients.
Understanding Lung Cancer
Beyond the Diagnosis
Types of Lung Cancer
- Non-Small Cell Lung Cancer (NSCLC):
- Adenocarcinoma: often peripheral
- Squamous cell carcinoma: typically central/bronchial
- Large cell carcinoma: can arise anywhere; faster-growing
- Small Cell Lung Cancer (SCLC): rapid growth and early spread
- Mesothelioma: cancer of the pleura (asbestos-associated)
- Pulmonary Carcinoid Tumors: rare, slower-growing neuroendocrine tumors
Conventional Treatment Limitations
- Surgery: limited to early stages; many patients have reduced lung reserve.
- Radiation: can injure healthy lung and worsen dyspnea; limited for widespread disease.
- Chemotherapy: systemic but taxing; may suppress immunity and energy.
- Targeted therapies: benefit mutation-positive patients; resistance often emerges.
- Checkpoint inhibitors: promising, but response rates vary, and immune side effects occur.
- Respiratory support: often under-emphasized in standard pathways.
Why a Comprehensive Approach Matters
We address:
- Cancer stem cells and circulating tumor cells
- Tumor microenvironment and chronic inflammation
- Immune function and metabolic health
- Respiratory capacity, oxygen utilization, and symptom relief
- Nutrition, stress, and emotional/spiritual resilience
The Oasis of Hope Approach to Lung Cancer
Core Principles
- Target cancer via multiple, complementary mechanisms
- Strengthen innate healing and immune surveillance, with special attention to lung function
- Treat the whole person—body, mind, and spirit
Comprehensive Assessment
- Medical & Exposure History: prior therapies/outcomes, tobacco/environmental exposure, comorbid lung disease.
- Advanced Diagnostics: imaging and labs plus circulating tumor cells, immune panels, inflammatory and nutritional markers, and when appropriate pulmonary function testing.
- Molecular Profiling: histology, actionable mutations (e.g., EGFR, ALK, ROS1), and PD-L1 expression to inform integration.
Personalized Treatment Protocol
Depending on your needs, your plan may include:
- ImPACT (Immune Autologous Cell Therapy Program): Our flagship, multi-modality immunotherapy coordinating dendritic cell therapy with adoptive cellular approaches (NK/LAK/T cells) to enhance systemic recognition of lung cancer—including circulating and therapy-resistant cells.
- Adoptive Immunotherapy: Expansion/activation of NK and T-lymphocytes with reinfusion to amplify anti-cancer activity.
- Metabolic Therapy: Ketogenic nutrition, strategic fasting, metabolic-targeting medications (e.g., metformin), and nutraceuticals that influence tumor energetics.
- Intravenous Therapies: High-dose vitamin C, intravenous curcumin, and other IV protocols that support immunity and target tumor biology.
- Ozone Therapy: Supports oxygen delivery/utilization, modulates inflammation, and can potentiate other therapies.
- Respiratory Support: Nebulized antioxidants (e.g., glutathione), breathing therapy, airway clearance strategies, oxygen optimization, and herbal formulations that support lung tissue.
- Targeted Supplementation: Evidence-informed compounds (e.g., medicinal mushrooms, modified citrus pectin) tailored to lung cancer biology.
- Nutritional Protocol: Anti-inflammatory, immune-supportive diet with personalized coaching.
- Mind-Body Medicine: Stress reduction, guided imagery, breathwork, counseling, and spiritual support.
Integrating with Conventional Care
- During Conventional Treatment: Reduce side effects, protect lung function, and support immunity around chemo, radiation, targeted therapy, or immunotherapy.
- Recovery & Maintenance: Rebuild respiratory capacity and reduce recurrence risk.
- Monitoring & Follow-Up: Clinical assessment, imaging as indicated, CTCs, immune/metabolic markers, pulmonary function, and quality-of-life tracking.
Tailored by Lung Cancer Type
- NSCLC: Local + systemic strategies with immune-metabolic focus.
- SCLC: Intensified systemic, immune-centric protocols for aggressive biology.
- Mesothelioma: Emphasis on pleural inflammation control and respiratory function.
- Early-Stage: Prevent progression/spread while preserving lung capacity.
- Advanced/Metastatic: Multi-modal systemic control with symptom relief and QOL emphasis.
Cancer Types
Clinical Observations
- Improved quality of life during and after treatment
- Enhanced respiratory comfort and exercise tolerance in many patients
- Reduction of symptoms (cough, dyspnea, chest discomfort)
- Tumor stabilization or regression in responsive cases
- Extended survival in select advanced cases
- Typically fewer side effects vs. conventional treatment alone
Patient Stories
(Individual results vary; we discuss realistic expectations during your consultation.)
FAQs:
Lung Cancer Treatment
Yes. We often integrate with standard care to improve tolerance and outcomes.
Plans reflect histology (NSCLC/SCLC), mutation status (e.g., EGFR/ALK/ROS1), PD-L1 expression, disease stage, and overall health.
We focus on systemic immune-metabolic control, symptom relief, and quality of life—often alongside targeted or immune agents.
Many patients report respiratory symptom relief with our lung-supportive strategies, though results vary by disease extent and lung reserve.
Typically 1-2 weeks onsite for intensive care, followed by a home maintenance plan with periodic boosters and monitoring.
Clinical exams, symptom tracking, labs (including immune/metabolic markers), CTC testing when appropriate, imaging, and pulmonary function tests as indicated.
Results vary. We’ll discuss expectations based on your cancer type, stage, prior therapies, and overall health.
Become a Patient
Take the first step toward personalized, integrative cancer care designed around your unique needs. Connect with our team today to explore your options and begin your journey with Oasis of Hope.
